ACCURAY INC 8-K

What Happened

• Accuray Inc. (ARAY) announced it received a notice from the Nasdaq Listing Qualifications Department on February 2, 2026 that it is not in compliance with Nasdaq Listing Rule 5550(a)(2) (the $1 minimum bid-price rule), based on the closing bid for the last 30 consecutive business days. The company’s common stock continues to trade on Nasdaq under the symbol “ARAY.”
• Nasdaq has provided a 180-calendar-day compliance period ending August 3, 2026 for Accuray to regain compliance by maintaining a closing bid of at least $1.00 for a minimum of ten consecutive business days (subject to possible extension by Nasdaq).

Key Details

• Notice date: February 2, 2026; Compliance deadline: August 3, 2026 (180 days).
• To regain compliance: closing bid ≥ $1.00 for at least 10 consecutive business days (Nasdaq may extend the 10‑day requirement).
• If not cured, Accuray may be eligible for a second 180‑day period by transferring to the Nasdaq Capital Market, which would require a transfer application, fee, meeting other initial listing standards (except the bid‑price rule), and potentially effecting a reverse stock split.
• The company is evaluating options and “intends to timely regain compliance,” but warned there is no assurance it will succeed.

Why It Matters

• This filing signals a material listing risk: if Accuray does not meet Nasdaq’s bid‑price requirement within the compliance period (or secure an available second period), Nasdaq could begin delisting proceedings.
• For investors, failure to cure could affect share liquidity, marketability, and investor perception; the company may consider actions (e.g., reverse stock split) to restore compliance.
• The stock continues to trade on Nasdaq now, but the outcome of the compliance process is important near‑term news for holders and potential investors.